Skip to content

Opening book details…

About this Medicine article

Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults by Garau, J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Garau, J.
Publisher
Oxford University Press; Oxford University Press (OUP) (ISSN 0305-7453)
Published
2003
Language
EN
Field
Medicine (Health Sciences)

More by Garau, J.

Browse all works by Garau, J.